ScholarIQanswers from OpenAlex

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma

PaperCitations, authors & open-access status

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma have?

ScholarIQcitation count

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma has 203 citations in the OpenAlex counts ScholarIQ stores.

When was Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma published?

ScholarIQyear

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma has 2015 year in the ScholarIQ index.

What is the open-access status of Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma?

ScholarIQoa status

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma has green oa status in the ScholarIQ index.

What is the DOI of Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma?

ScholarIQdoi

The DOI for Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma is on the source record.

What is the PMID of Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma?

ScholarIQpmid

The PMID for Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma is on the source record.

What is the OpenAlex record for Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma?

ScholarIQopenalex

The OpenAlex for Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial